openPR Logo
Press release

Albumin Market - High prevalence of different types of life-threatening cases and upsurge in adoption of albumin-based therapy drive the growth of the market

04-05-2019 11:12 AM CET | Health & Medicine

Press release from: Allied Market Research

Albumin Market

Albumin Market

According to a new report in the Allied Market Research, Global Opportunity Analysis and Industry Forecast, 2017-2023, "The global albumin market in 2016 was valued at $ 5,381 million, and in 2023 $10,305 million to reach an annual average growth rate of 9.6% from 2017 to 2023.

Albumin is a spherical protein found in the blood's liquid component called plasma. It is the most abundant protein in plasma, accounting for about 50% of total protein. It plays an important role in maintaining proper intra-tumor pressure of blood and transporting hormones, fatty acids and other compounds throughout the body. It is extracted from plasma at the time of cleavage and widely used clinically to treat various diseases. Other types of albumin are used clinically. These include human serum albumin, bovine serum albumin and recombinant albumin.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2583

The factors that drive the growth of the albumin market include increase in prevalence of life-threatening diseases and conditions namely surgical procedures, liver diseases, trauma and burns cases, and others. Moreover, rise in awareness about recombinant albumin products, upsurge in demand for albumin products, and growth in non-therapeutic application of albumin also fuel the growth of the market. However, stringent governmental regulations and reforms, and risk of side effects associated after using albumin products impede the market growth. Conversely, the development of cost-effective therapeutic along with large production of albumin and presence of untapped market in emerging economies are expected to provide lucrative growth opportunities for the market.

The human serum albumin segment accounted for the largest share in 2016, owing to high usage as blood volumizer and applicability for treating variety of diseases and improved human serum albumin production due to the emergence of advanced technologies. However, the recombinant albumin segment is expected to grow at the high CAGR from 2017 to 2023.

The utilization rate of albumin for therapeutics is high owing to rise in prevalence of trauma and cases of burns as well as increase in the number of surgical procedures. However, drug formulation and vaccines segment is expected to grow at a high CAGR during the forecast period.

Flat 20% Discount on All Type of License (https://www.alliedmarketresearch.com/checkout/726272) * Offer Valid Till 20th April 2019

Key Findings of the Albumin Market:
• The bovine serum albumin segment accounted for nearly one-eighth share of the global albumin market in 2016.
• The recombinant albumin segment is expected to grow at highest CAGR from 2017 to 2023.
• The component of media segment accounted for around one-fifth share of the global market in 2016.
• Europe accounted for around one-third share of the global market in 2016.
• LAMEA is expected to provide lucrative market growth opportunities from 2017 to 2023.

North America was the leading revenue contributor to the global albumin market in 2016, and is expected to dominate the market during the forecast period. This is attributed to the early approval of albumin products and high adoption of recombinant albumin in this region. However, Asia-Pacific is expected to grow at the highest CAGR during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness toward albumin products.

Access Full Summery @ https://www.alliedmarketresearch.com/human-albumin-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Albumin Market - High prevalence of different types of life-threatening cases and upsurge in adoption of albumin-based therapy drive the growth of the market here

News-ID: 1690192 • Views: 360

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Albumin

Global Serum Albumin Market Research Report
This report studies the global Serum Albumin market status and forecast, categorizes the global Serum Albumin market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Octapharma Kedrion CSL Behring Shire (Baxter) Grifols Hualan Bio Taibang Bio RAAS Greencross Geographically, this report studies
Global Glycated Albumin Market Growth 2019-2024
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy. Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose
Glycated Albumin Market
Market players and various research organisations are engaged in developing novel diagnostic tests using glycated albumin in order to meet increasing demand from end-use industries. For instance, in 2016, according to a study published in journal Nephrology Dialysis Transplantation reported that glycated albumin might provide a valuable alternative for predicting mortality in diabetic patients on hemodialysis. Furthermore, leading players in the market are focused on new product launches and its
Global Albumin Market $307 Million by 2021
According to a market research report Albumin Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc., the global albumin market is estimated to reach $307 Million in 2021, expanding at a CAGR of 2.4% from 2017 to 2021. The global albumin market segmentation is based on type (human serum albumin, bovine serum albumin, recombinant albumin), and its applications (drug formulation and drug delivery, vaccines, components of media). The global albumin market
Global Glycated Albumin Sales Market Report 2017
24 Market Reports provides a complete data analysis of Global Glycated Albumin Sales Market Report 2017 with Market value, Sales, Price, Industry Analysis and Forecast with the help of Industry Experts. In this report, the global Glycated Albumin market is expected to reach high by the end of 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Glycated
Latest market Research | Glycated Albumin Sales 2017
This report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Glycated Albumin for these regions, from 2012 to 2022 (forecast), covering • United States • China • Europe • Japan • Southeast Asia • India Global Glycated Albumin market competition by top manufacturers/players, with Glycated Albumin sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including • Asahi Kasei Pharma • DIAZYME • Abnova • LifeSpan • Exocell • BSBE • Medicalsystem • Maccura • Leadman • Simes Sikma • NINGBO PUREBIO On the basis of product, this